According to Immunocore's latest financial reports the company's current revenue (TTM) is $0.31 B. In 2022 the company made a revenue of $0.17 B an increase over the years 2021 revenue that were of $36.15 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.31 B | 81.14% |
2022 | $0.17 B | 377.41% |
2021 | $36.15 M | -6.01% |
2020 | $38.47 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |